BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 33072567)

  • 1. Lack of Racial Survival Differences in Metastatic Prostate Cancer in National Cancer Data Base (NCDB): A Different Finding Compared to Non-metastatic Disease.
    Vengaloor Thomas T; Gordy XZ; Lirette ST; Albert AA; Gordy DP; Vijayakumar S; Vijayakumar V
    Front Oncol; 2020; 10():533070. PubMed ID: 33072567
    [No Abstract]   [Full Text] [Related]  

  • 2. Racial/ethnic disparities in de novo metastases sites and survival outcomes for patients with primary breast, colorectal, and prostate cancer.
    Akinyemiju T; Sakhuja S; Waterbor J; Pisu M; Altekruse SF
    Cancer Med; 2018 Apr; 7(4):1183-1193. PubMed ID: 29479835
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Racial disparities in palliative care utilization among metastatic gynecological cancer patients living at last follow-up: An analysis of the National Cancer Data Base.
    Islam JY; Deveaux A; Previs RA; Akinyemiju T
    Data Brief; 2021 Feb; 34():106705. PubMed ID: 33473361
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Racial differences in the distribution of bladder cancer metastases: a population-based analysis.
    Rosiello G; Palumbo C; Deuker M; Stolzenbach LF; Martin T; Tian Z; Gallina A; Montorsi F; Black P; Kassouf W; Shariat SF; Saad F; Briganti A; Karakiewicz PI
    Cent European J Urol; 2020; 73(4):407-415. PubMed ID: 33552564
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Past, Current, and Future Incidence Rates and Burden of Metastatic Prostate Cancer in the United States.
    Kelly SP; Anderson WF; Rosenberg PS; Cook MB
    Eur Urol Focus; 2018 Jan; 4(1):121-127. PubMed ID: 29162421
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Race does not predict the development of metastases in men with nonmetastatic castration-resistant prostate cancer.
    Whitney CA; Howard LE; Amling CL; Aronson WJ; Cooperberg MR; Kane CJ; Terris MK; Freedland SJ
    Cancer; 2016 Dec; 122(24):3848-3855. PubMed ID: 27505036
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence trends and survival of metastatic prostate cancer with bone and visceral involvement: 2010-2019 surveillance, epidemiology, and end results.
    Kadeerhan G; Xue B; Wu XL; Chen WN; Wang DW
    Front Oncol; 2023; 13():1201753. PubMed ID: 37601697
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Might men diagnosed with metastatic prostate cancer benefit from definitive treatment of the primary tumor? A SEER-based study.
    Culp SH; Schellhammer PF; Williams MB
    Eur Urol; 2014 Jun; 65(6):1058-66. PubMed ID: 24290503
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prostate cancer metastasis and health disparities: a systematic review.
    Liadi Y; Campbell T; Dike P; Harlemon M; Elliott B; Odero-Marah V
    Prostate Cancer Prostatic Dis; 2024 Jun; 27(2):183-191. PubMed ID: 37046071
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Racial Differences in the Diagnosis and Treatment of Prostate Cancer.
    Pietro GD; Chornokur G; Kumar NB; Davis C; Park JY
    Int Neurourol J; 2016 Nov; 20(Suppl 2):S112-119. PubMed ID: 27915474
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Racial disparity in prostate cancer: an outlook in genetic and molecular landscape.
    Kaushal JB; Raut P; Muniyan S; Siddiqui JA; Alsafwani ZW; Seshacharyulu P; Nair SS; Tewari AK; Batra SK
    Cancer Metastasis Rev; 2024 Jun; ():. PubMed ID: 38902476
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improved Survival With Prostate Radiation in Addition to Androgen Deprivation Therapy for Men With Newly Diagnosed Metastatic Prostate Cancer.
    Rusthoven CG; Jones BL; Flaig TW; Crawford ED; Koshy M; Sher DJ; Mahmood U; Chen RC; Chapin BF; Kavanagh BD; Pugh TJ
    J Clin Oncol; 2016 Aug; 34(24):2835-42. PubMed ID: 27325855
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of the contribution of demographics, access to health care, treatment, and tumor characteristics to racial differences in survival of advanced prostate cancer.
    Krimphove MJ; Cole AP; Fletcher SA; Harmouch SS; Berg S; Lipsitz SR; Sun M; Nabi J; Nguyen PL; Hu JC; Kibel AS; Choueiri TK; Kluth LA; Trinh QD
    Prostate Cancer Prostatic Dis; 2019 Mar; 22(1):125-136. PubMed ID: 30171227
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Racial disparities in treatment and survival of patients with hepatocellular carcinoma in the United States.
    Xu L; Kim Y; Spolverato G; Gani F; Pawlik TM
    Hepatobiliary Surg Nutr; 2016 Feb; 5(1):43-52. PubMed ID: 26904556
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic Impacts of Metastatic Site and Pain on Progression to Castrate Resistance and Mortality in Patients with Metastatic Prostate Cancer.
    Koo KC; Park SU; Kim KH; Rha KH; Hong SJ; Yang SC; Chung BH
    Yonsei Med J; 2015 Sep; 56(5):1206-12. PubMed ID: 26256961
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of socioeconomic status, race, and insurance type on newly diagnosed metastatic prostate cancer in the United States (2004-2013).
    Weiner AB; Matulewicz RS; Tosoian JJ; Feinglass JM; Schaeffer EM
    Urol Oncol; 2018 Mar; 36(3):91.e1-91.e6. PubMed ID: 29153624
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Psychosocial Stress, Glucocorticoid Signaling, and Prostate Cancer Health Disparities in African American Men.
    Woods-Burnham L; Stiel L; Martinez SR; Sanchez-Hernandez ES; Ruckle HC; Almaguel FG; Stern MC; Roberts LR; Williams DR; Montgomery S; Casiano CA
    Cancer Health Disparities; 2020; 4():. PubMed ID: 35252767
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Investigating disparities: the effect of social environment on pancreatic cancer survival in metastatic patients.
    Madnick D; Handorf E; Ortiz A; Sorice K; Nagappan L; Moccia M; Cheema K; Vijayvergia N; Dotan E; Lynch SM
    J Gastrointest Oncol; 2020 Aug; 11(4):633-643. PubMed ID: 32953147
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Racial disparities in preoperative chemotherapy use in gastric cancer patients in the United States: Analysis of the National Cancer Data Base, 2006-2014.
    Ikoma N; Cormier JN; Feig B; Du XL; Yamal JM; Hofstetter W; Das P; Ajani JA; Roland CL; Fournier K; Royal R; Mansfield P; Badgwell BD
    Cancer; 2018 Mar; 124(5):998-1007. PubMed ID: 29393964
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Racial/Ethnic Disparity in Treatment for Prostate Cancer: Does Cancer Severity Matter?
    Moses KA; Orom H; Brasel A; Gaddy J; Underwood W
    Urology; 2017 Jan; 99():76-83. PubMed ID: 27667157
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.